Microbial Features Linked to Medication Strategies in Cardiometabolic Disease Management.
Ontology highlight
ABSTRACT: Human gut microbiota are recognized as critical players in both metabolic disease and drug metabolism. However, medication-microbiota interactions in cardiometabolic diseases are not well understood. To gain a comprehensive understanding of how medication intake impacts the gut microbiota, we investigated the association of microbial structure with the use of single or multiple medications in a cohort of 134 middle-aged adults diagnosed with cardiometabolic disease, recruited from Alberta's Tomorrow Project. Predominant cardiometabolic prescription medication classes (12 total) were included in our analysis. Multivariate Association with Linear Model (MaAsLin2) was employed and results were corrected for age, BMI, sex, and diet to evaluate the relationship between microbial features
SUBMITTER: Shearer J
PROVIDER: S-EPMC11040554 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA